CM
GILD icon

CS McKee’s Gilead Sciences GILD Stock Holding History

CS McKee’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$10.9M Buy
168,350
+21,350
+15% +$1.39M 1% 45
2019
Q3 		$9.32M Buy
147,000
+14,500
+11% +$948K 0.84% 47
2019
Q2 		$8.95M Sell
132,500
-100
-0.1% -$6.58K 0.79% 47
2019
Q1 		$8.62M Hold
132,600
– – 0.76% 49
2018
Q4 		$8.29M Sell
132,600
-2,200
-2% -$154K 0.82% 49
2018
Q3 		$10.4M Sell
134,800
-1,900
-1% -$143K 0.83% 49
2018
Q2 		$9.68M Sell
136,700
-5,700
-4% -$403K 0.82% 50
2018
Q1 		$10.7M Sell
142,400
-2,900
-2% -$231K 0.84% 50
2017
Q4 		$10.4M Sell
145,300
-900
-0.6% -$68.3K 0.78% 53
2017
Q3 		$11.8M Sell
146,200
-300
-0.2% -$22.9K 0.92% 49
2017
Q2 		$10.4M Buy
146,500
+300
+0.2% +$20K 0.83% 50
2017
Q1 		$9.93M Sell
146,200
-1,400
-0.9% -$98.4K 0.79% 49
2016
Q4 		$10.6M Sell
147,600
-22,300
-13% -$1.66M 0.81% 51
2016
Q3 		$13.4M Sell
169,900
-24,150
-12% -$1.96M 0.86% 47
2016
Q2 		$16.2M Sell
194,050
-35,500
-15% -$3.15M 0.69% 54
2016
Q1 		$21.1M Sell
229,550
-29,900
-12% -$2.7M 0.77% 52
2015
Q4 		$26.3M Sell
259,450
-6,850
-3% -$713K 0.84% 49
2015
Q3 		$26.1M Sell
266,300
-9,000
-3% -$1,000K 0.85% 47
2015
Q2 		$32.2M Sell
275,300
-17,100
-6% -$1.87M 0.89% 47
2015
Q1 		$28.7M Sell
292,400
-13,700
-4% -$1.39M 0.75% 49
2014
Q4 		$28.9M Sell
306,100
-4,480
-1% -$463K 0.7% 50
2014
Q3 		$33.1M Sell
310,580
-2,700
-0.9% -$264K 0.76% 51
2014
Q2 		$26M Buy
+313,280
New +$24.4M 0.55% 53

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CS McKee's GILD Position: Q4 2019 in Review

CS McKee increased its Gilead Sciences (GILD) stake by 15% in Q4 2019, buying an estimated $1.39M and bringing the position to 168,350 shares worth $10.9M. The position accounts for 1% of the portfolio, ranked #45.

CS McKee first reported a position in GILD in Q2 2014 and has held it in 23 quarters since. The position peaked at $33.1M in Q3 2014. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • CS McKee held 168,350 shares of Gilead Sciences worth $10.9M as of Q4 2019.
  • CS McKee bought 21,350 Gilead Sciences shares in Q4 2019, an estimated $1.39M.
  • Gilead Sciences made up 1% of CS McKee's portfolio in Q4 2019, its #45 holding.
  • CS McKee first reported a position in Gilead Sciences in Q2 2014 and has held it in 23 quarters since.
  • CS McKee's Gilead Sciences position peaked at $33.1M in Q3 2014.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on CS McKee's 13F filing for Q4 2019, filed 14 Feb 2020.